The launch of the vaccine named, Vanguard CIV H3N2 / H3N8 Vaccine, was announced in December 2017 by Zoetis. This was the most recent vaccine in the list of the company's canine influenza vaccine portfolio. Such initiatives taken by companies towards the launch of vaccines to protect animals from various diseases is promoting the growth of the global veterinary vaccines market, predicts Fortune Business Insights in their new report.

For more information in the analysis of this report, visit: 

Fortune Business Insights foresees the global market for veterinary vaccines to rise because of the increasing number of pet adopters worldwide. In a report, titled “Veterinary Vaccines Market Size, Share & Industry Analysis, By Product (Inactivated, Live Attenuated, Recombinant, Others) , By Animal (Companion, Livestock), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others) and Regional Forecast, 2019-2026 ”it offers an overview It also provides recommendations to help market players gain competitive edge.

According to the report, the market is anticipated to rise from a value of USD 9.75 Billion in 2018 to USD 16.01 Billion by 2026. The forecast period is set from 2019 to 2026 and the market is expected to rise at a CAGR of 6.4%.

The global veterinary vaccines market is segmented on the basis of product, animal, and route of administration, distribution channel, and geography. Among these, the parental animal vaccines segment will earn the highest revenue in the forecast duration with respect to route of administration. This is owing to the fact that parental animal vaccines are among the most traditional and common forms of vaccinations. On the other side, the companion animal segment is prognosticated to grow at rapid CAGR in the forecast period, with respect to animal. to the rise in number of pet ownership on a worldwide basis.

Rise in Disposable Income to Help Asia Pacific Market Grow Rapidly

The global veterinary vaccines market was dominated by North America with a revenue generation of US $ 2.97 billion in 2018 AND Fortune Business Insights predicts this region to continue its dominance in the forecast period as well owing to the rapid adoption of efficient veterinary vaccines. This, Accompanied by the use of technologically advanced vaccine delivery across all regions is anticipated to help North America remain dominant.